| Page 595 | Kisaco Research

Uncover how you can design value added benefits programmes through community collaboration from leaders who have successfully designed, implemented, and measured
outcomes of these benefits

Author:

Lonie Haynes

SVP Chief Diversity, Health Equity, Inclusion and Justice Officer
Rochester Regional Health
... read more

Lonie Haynes

SVP Chief Diversity, Health Equity, Inclusion and Justice Officer
Rochester Regional Health

Author:

Shannon Wilson

Vice President Population Health & Health Equity
Priority Health
... read more

Shannon Wilson

Vice President Population Health & Health Equity
Priority Health

Author:

Robyn Bussey

Director, Just Health
Partnership for Southern Equity
... read more

Robyn Bussey

Director, Just Health
Partnership for Southern Equity
 

Laure Cahuzac

Head of Development
Bacthera

Laure Cahuzac

Head of Development
Bacthera

Laure Cahuzac

Head of Development
Bacthera
 

Jun Kunisawa

Director, Microbial Research Center
NIBIOHN

Jun Kunisawa

Director, Microbial Research Center
NIBIOHN

Jun Kunisawa

Director, Microbial Research Center
NIBIOHN
 

Christian Eberle

Chief Executive Officer
Bacthera

Christian Eberle

Chief Executive Officer
Bacthera

Christian Eberle

Chief Executive Officer
Bacthera
 

Sabu Thomas

Director
Centre of Excellence in Microbiome, Govt. of Kerala (India)

Sabu Thomas

Director
Centre of Excellence in Microbiome, Govt. of Kerala (India)

Sabu Thomas

Director
Centre of Excellence in Microbiome, Govt. of Kerala (India)
 

Jisoo Pae

Chief Executive Officer
Genome & Company

Jisoo Pae

Chief Executive Officer
Genome & Company

Jisoo Pae

Chief Executive Officer
Genome & Company
 

Yeung-Hyen Kim

Chief Technology Officer
Liveome

Yeung-Hyen Kim

Chief Technology Officer
Liveome

Yeung-Hyen Kim

Chief Technology Officer
Liveome
 

GwangPyo Ko

Chief Executive Officer
KoBioLabs

GwangPyo Ko

Chief Executive Officer
KoBioLabs

GwangPyo Ko

Chief Executive Officer
KoBioLabs
 

Yosep Ji

Chief Executive Officer
HEM Pharma

Yosep Ji

Chief Executive Officer
HEM Pharma

Yosep Ji

Chief Executive Officer
HEM Pharma
  • Investigate cutting-edge wound care tech and personalized medicine.
  • Navigate changing regulations, prioritize standardized protocols, and promote patient engagement through education and home-based care.
  • Evaluate economic impacts, enhance reimbursement models, and address accessibility challenges

Author:

Kevin Richardson

CEO
Qualigen Therapeutics
... read more

Kevin Richardson

CEO
Qualigen Therapeutics

Author:

Emma Wright

CMO
Mölnlycke

Emma is an industry professional with 25 years of experience in medical devices in both start-up and international companies, based in UK, US and most recently in Sweden.  Her career has been focused on the development and commercialisation of devices in wound care, reconstructive surgery and orthopedics with a specific interest in products that actively promote tissue repair.  In the last 10 years Emma has led clinical, medical and health economic teams with responsibility for clinical evidence generation, professional education, medical affairs and health economics. 

... read more

Emma Wright

CMO
Mölnlycke

Emma is an industry professional with 25 years of experience in medical devices in both start-up and international companies, based in UK, US and most recently in Sweden.  Her career has been focused on the development and commercialisation of devices in wound care, reconstructive surgery and orthopedics with a specific interest in products that actively promote tissue repair.  In the last 10 years Emma has led clinical, medical and health economic teams with responsibility for clinical evidence generation, professional education, medical affairs and health economics. 

Author:

Kris Kieswetter

Senior Director, Research and Technology
3M
... read more

Kris Kieswetter

Senior Director, Research and Technology
3M